Serge Muyldermans

33.6k citations
291 papers · 25.6k indexed · 9 hit papers · h-index 80
Topics
Monoclonal and Polyclonal Antibodies Research (205 papers)Glycosylation and Glycoproteins Research (106 papers)Protein purification and stability (27 papers)

In The Last Decade

Serge Muyldermans

286 papers receiving 25.1k citations

Hit Papers

Naturally occurring antibodies devoid of light chains19932026200420151993201319972014200750010001.5k2.0k

Peers

Serge Muyldermans
Comparison fields: 5 of 157
  • Molecular Biology 16.6k
  • Radiology, Nuclear Medicine and Imaging 16.3k
  • Immunology 5.8k
  • Oncology 2.9k
  • Biomedical Engineering 2.2k
Replace Andreas Plückthun with:
Andreas Plückthun Switzerland
Pauline M. Rudd United Kingdom
Pamela J. Björkman United States
Georges Köhler Germany
César Milstein United Kingdom
Greg Winter United Kingdom
Hidde L. Ploegh United States
James C. Paulson United States
David R. Davies United States
Ari Helenius Switzerland
Serge Muyldermans relative to Andreas Plückthun Switzerland Andreas Plückthun's profile →
Citations per field
00.5×1.7×
Andreas Plückthun · 1×
Citations per year

Countries citing papers authored by Serge Muyldermans

Since Specialization
Citations

This map shows the geographic impact of Serge Muyldermans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serge Muyldermans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serge Muyldermans more than expected).

Fields of papers citing papers by Serge Muyldermans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serge Muyldermans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serge Muyldermans. The network helps show where Serge Muyldermans may publish in the future.

Co-authorship network of co-authors of Serge Muyldermans

This figure shows the co-authorship network connecting the top 25 collaborators of Serge Muyldermans. A scholar is included among the top collaborators of Serge Muyldermans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serge Muyldermans. Serge Muyldermans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 11
3 3
4 17
5 12
6 27
7 55
8 69
9 40
10 36
11 8
12 31
13 3
14
Nanobody-coupled microbubbles as novel molecular tracer.
1
15 85
16 55
17 265
18 109
19 62
20 46

About Serge Muyldermans

Serge Muyldermans is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Molecular Biology, having authored 291 papers that have together received 25.6k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (205 papers), Glycosylation and Glycoproteins Research (106 papers) and Protein purification and stability (27 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (16.3k citations), Immunology (5.8k citations) and Molecular Biology (16.6k citations). Serge Muyldermans has collaborated with scholars based in Belgium, China and United Kingdom. Frequent co-authors include Lode Wyns, Katja Conrath, Dirk Saerens, Nick Devoogdt, R. Hamers, Cécile Vincke, T. Atarhouch, Aline Desmyter, G. Robinson and C. Hamers‐Casterman. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026